Cite
HARVARD Citation
Gooch, K. et al. (2021). One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model. Vaccine. 39 (34), pp. 4885-4894. [Online].